Indication
Diabetes mellitus
Diabetes mellitus is a chronic metabolic disorder affecting the endocrine and vascular systems, characterized by persistent hyperglycemia resulting from impaired insulin secretion, reduced insulin sensitivity, or both. Read more about Diabetes mellitus
89 drugs 7 manufacturers
Drugs that treat it
Common Diabetes mellitus therapies.
FIASP FLEXTOUCH U-100 INSULIN (insulin aspart (niacinamide))
HUMALOG JUNIOR KWIKPEN U-100 (insulin lispro)
ADMELOG U-100 INSULIN LISPRO (insulin lispro)
ADMELOG SOLOSTAR U-100 INSULIN (insulin lispro)
NOVOLIN 70-30 FLEXPEN U-100 (insulin NPH human isophane/insulin regular, human)
HUMALOG TEMPO PEN(U-100)INSULN (insulin lispro)
LYUMJEV TEMPO PEN(U-100)INSULN (insulin lispro-aabc)
NOVOLIN 70/30 U-100 INSULIN (insulin NPH human isophane/insulin regular, human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetes mellitus is a chronic metabolic disorder affecting the endocrine and vascular systems, characterized by persistent hyperglycemia resulting from impaired insulin secretion, reduced insulin sensitivity, or both.
The condition encompasses heterogeneous etiologies—primarily absolute insulin deficiency due to autoimmune pancreatic beta-cell destruction or progressive relative insulin deficiency coupled with peripheral insulin resistance.
Clinically, it manifests with classic osmotic symptoms such as polyuria, polydipsia, and unexplained weight loss, alongside systemic metabolic disruptions.
Over time, chronic hyperglycemia leads to widespread microvascular and macrovascular complications, notably retinopathy, nephropathy, peripheral neuropathy, and an increased risk of cardiovascular disease.
- nih.gov
Diabetes mellitus is a chronic metabolic disorder affecting the endocrine and vascular systems, characterized by persistent hyperglycemia resulting from impaired insulin secretion, reduced insulin sensitivity, or both The condition encompasses heterogeneous etiologies—primarily absolute insulin deficiency due to autoimmune pancreatic beta-cell destruction or progressive relative insulin deficiency coupled with peripheral insulin resistance Over time, chronic hyperglycemia leads to widespread mic...
- nih.gov
Diabetes mellitus is a chronic metabolic disorder affecting the endocrine and vascular systems, characterized by persistent hyperglycemia resulting from impaired insulin secretion, reduced insulin sensitivity, or both
- nih.gov
The condition encompasses heterogeneous etiologies—primarily absolute insulin deficiency due to autoimmune pancreatic beta-cell destruction or progressive relative insulin deficiency coupled with peripheral insulin resistance
- nih.gov
Clinically, it manifests with classic osmotic symptoms such as polyuria, polydipsia, and unexplained weight loss, alongside systemic metabolic disruptions
- nih.gov
Clinically, it manifests with classic osmotic symptoms such as polyuria, polydipsia, and unexplained weight loss, alongside systemic metabolic disruptions
Personalize your experience
Follow Diabetes mellitus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.